Today, the FDA's Vaccines and Related Biological Products Advisory Committee voted 17 to 4 in support of the FDA granting...
Pfizer, BioNTech Receive FDA Advisory Approval for COVID-19 Vaccine Emergency Use in The US
biontech
Pfizer/BioNTech COVID-19 Vaccine Concludes Final Phase Testing
Pfizer announced today the successful conclusion of their mRNA-based BNT162b2 vaccine for SARS-CoV-2 produced in partnership with BioNTech. This news comes shortly after...
No, The Pfizer COVID-19 Vaccine Was Not the "Tireless Work" of OWS
Yesterday, Ivanka Trump tweeted the news of 90% efficacy in Pfizer and BioNTech's BNT162 mRNA-based vaccine to combat COVID-19. She then made the bold...
Pfizer, BioNTech to Supply Canada with COVID-19 Vaccine
In an annoucement today from Pfizer, the Government of Canada has entered into an agreement with the Pfizer and BioNTech to supply the partnership's BNT162 mRNA-based vaccine to combat COVID-19.
Lead COVID-19 mRNA Vaccine Chosen for Pfizer, BioNTech PII/III Study
Today Pfizer and BioNTech have jointly announced they are prepared to begin their Phase II/III global trials for their COVID-19 vaccine partnership. Following on review of Phase I/II trial results, the partnership worked with the FDA to select BNT162b2 as the vaccine candidate in the next phases.
Pfizer, BioNTech Early Positive COVID-19 PI/II Vaccine Results
In a news release today, the BNT162b1 COVID-19 vaccine under development by Pfizer and BioNTech displayed early positive results in producing neutralizing antibodies from the partnership's Phase I/II trial.